TS

TRAVERSA SERGIO

Cumul. flow

0

Total declarations

0

Company

€423,760

▲ Purchases (4 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

4

Disclosed sells

0

T+90 hit rate

0%

T+90 mean return

-61.3%

Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Browse the full record of transactions filed by TRAVERSA SERGIO. Director active across 1 company, notably Relmada Therapeutics, INC.. In total, 5 filings have been published. Split: 4 buys · 0 sell. Total volume traded: €424k. Activity tracked since 30 June 2022. The latest transaction was filed on 16 May 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.

Declarations5 total

▲

TRAVERSA SERGIO

Chief Executive OfficerExecutives16 May 2025Relmada Therapeutics, INC.

$77,47247SEC ↗

172,314 shares@ US$0.449610.4% of flowCommon StockSEC:0001213900-25-046085:0

Ideal exit: 10 Feb 2026 (T+270)

▲

TRAVERSA SERGIO

Chief Executive OfficerExecutives9 Sept 2024Relmada Therapeutics, INC.

$150,61948SEC ↗

55,579 shares@ US$2.7120.4% of flowCommon StockSEC:0001213900-24-077795:0

Ideal exit: 6 Jun 2025 (T+270)

▲

TRAVERSA SERGIO

Chief Executive OfficerExecutives29 Jan 2024Relmada Therapeutics, INC.

$117,03639SEC ↗

31,541 shares@ US$3.710616.2% of flowCommon StockSEC:0001213900-24-008560:0

Ideal exit: 25 Oct 2024 (T+270)

▲

TRAVERSA SERGIO

Chief Executive OfficerExecutives8 Dec 2022Relmada Therapeutics, INC.

$115,80424SEC ↗

55,250 shares@ US$2.09616.5% of flowCommon StockSEC:0001213900-22-079244:0

Ideal exit: 4 Sept 2023 (T+270)

◇

TRAVERSA SERGIO

Chief Executive OfficerExecutives30 Jun 2022Relmada Therapeutics, INC.

$256,19226SEC ↗

16,012 shares@ US$16.0036.6% of flowCommon StockSEC:0001213900-22-037231:0

5 of 5 declarations

TRAVERSA SERGIO

Insider track record

Related entities

TRAVERSA SERGIO

Insider track record

Related entities